Navigating the Frontier of Oligonucleotide Therapeutics: Precision Characterization in a Complex Landscape
The rapid evolution of oligonucleotide therapeutics—spanning antisense oligonucleotides (ASOs), small interfering RNAs (siRNAs), aptamers, and the emerging classes of antibody-oligonucleotide...
